 8. Women of child-bearing potential and men must agree to use adequate contraception hormonal or barrier method of birth control for the duration of trial participation. Female patients with reproductive potential must have a negative serum pregnancy test within 7 days of trial enrolment. Breast feeding mothers will be excluded since these agents may be toxic to infants. 